Quick Answer
BriaCell Therapeutics Corp. reported Total Assets of $21.65 million for fiscal year 2025.
BriaCell Therapeutics Corp. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $21.65M | +268.7% |
| 2024 | $5.87M | -78.4% |
| 2023 | $27.16M | -36.2% |
| 2022 | $42.58M | -26.6% |
| 2021 | $58.04M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| October 31, 2025 | $13.08M | +25.5% | -39.6% |
| July 31, 2025 | $21.65M | +268.7% | +27.3% |
| April 30, 2025 | $17.00M | +174.1% | +81.6% |
| January 31, 2025 | $9.36M | -23.4% | -10.1% |
| October 31, 2024 | $10.41M | -44.1% | +77.3% |
| July 31, 2024 | $5.87M | -78.4% | -5.3% |
| April 30, 2024 | $6.20M | -79.1% | -49.3% |
| January 31, 2024 | $12.23M | -64.2% | -34.3% |
- BriaCell Therapeutics Corp. showed an increase of +268.7% in Total Assets compared to the prior fiscal year.
- Over the 2021–2025 period, BriaCell Therapeutics Corp.’s total assets has declined by 62.7% (from $58.04 million to $21.65 million).
- The most recent figure is from BriaCell Therapeutics Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on October 16, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: